Kaplan Fox & Kilsheimer LLP Encourages Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to Contact the Firm Regarding Potential Securities Law Violations
Kaplan Fox is investigating potential securities law violations by Madrigal Pharmaceuticals (NASDAQ: MDGL) after its stock fell on Nov. 3, 2026.
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


